Ί¬Πί²έ΄«Γ½

Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.24.1.u1
Stock-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2024
Schedule of number of cash-settled RSUs granted

​

​

​

​

​

​

​

​

Three months ended

​

​

​

​

MarchΜύ31, 2024

​

​

​

​

RSUs Granted (000's)

​

​

​

​

​

​

​

QRTEA time-based RSUs, subsidiary employees (1)

​

20,945

​

​

QRTEA performance-based RSUs, subsidiary employees (2)

​

20,305

​

​

QRTEA performance-based RSUs, Ί¬Πί²έ΄«Γ½ employees (3)

​

921

​

​
(1) Grants mainly vest equally over three years.
(2) Grants vest equally over three years, subject to the satisfaction of certain performance objectives.
(3) Grants vest one year from the month of grant, subject to the satisfaction of certain performance objectives.
Schedule of number and weighted average GDFV of RSUs granted to certain officers, employees and directors

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

Weighted

​

​

​

³§±π°ωΎ±±π²υΜύ΄‘

​

Average

​

³§±π°ωΎ±±π²υΜύ΅ώ

​

Average

​

​

​

(000's)

​

GDFV

​

(000's)

​

GDFV

​

RSUs outstanding at January 1, 2024

Μύ

14,691

​

$

3.30

​

353

​

$

5.51

​

Granted

Μύ

3,739

​

$

1.23

​

296

​

$

5.01

​

Vested

Μύ

(5,612)

​

$

3.73

​

(353)

​

$

4.85

​

Forfeited/Cancelled

Μύ

(1,115)

​

$

2.15

​

β€”

​

$

β€”

​

RSUs outstanding at March 31, 2024

Μύ

11,703

​

$

2.54

​

296

​

$

5.01

Μύ
Common Class A Μύ
Schedule of number, weighted average exercise price ("WAEP"), Weighted average remaining life and aggregate intrinsic value of the awards

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

ΜύΜύΜύΜύ

​

ΜύΜύΜύΜύ

​

​

ΜύΜύΜύΜύ

Weighted

ΜύΜύΜύΜύ

Aggregate

Μύ

​

​

​

​

​

​

​

average

​

intrinsic

​

​

​

³§±π°ωΎ±±π²υΜύ΄‘

​

​

​

​

remaining

​

value

​

​

​

(000's)

​

WAEP

​

life

​

(millions)

​

Options outstanding at January 1, 2024

Μύ

23,530

​

$

7.72

​

​

​

​

​

​

​

Granted

Μύ

β€”

​

$

β€”

​

​

​

​

​

​

​

Exercised

Μύ

β€”

​

$

β€”

​

​

​

​

​

​

​

Forfeited/Cancelled

Μύ

(2,849)

​

$

10.87

​

​

​

​

​

​

​

Options outstanding at MarchΜύ31, 2024

Μύ

20,681

​

$

7.29

Μύ

2.5

years

​

$

β€”

​

Options exercisable at MarchΜύ31, 2024

Μύ

18,333

​

$

7.13

Μύ

2.4

years

​

$

β€”

​
Common Class B Μύ
Schedule of number, weighted average exercise price ("WAEP"), Weighted average remaining life and aggregate intrinsic value of the awards

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

ΜύΜύΜύΜύ

​

ΜύΜύΜύΜύ

​

​

ΜύΜύΜύΜύ

Weighted

ΜύΜύΜύΜύ

Aggregate

Μύ

​

​

​

​

​

​

​

average

​

intrinsic

​

​

​

³§±π°ωΎ±±π²υΜύ΅ώ

​

​

​

​

remaining

​

value

​

​

​

(000's)

​

WAEP

​

life

​

(millions)

​

Options outstanding at January 1, 2024

Μύ

723

​

$

12.35

​

​

​

​

​

​

​

Granted

Μύ

β€”

​

$

β€”

​

​

​

​

​

​

​

Exercised

Μύ

β€”

​

$

β€”

​

​

​

​

​

​

​

Forfeited/Cancelled

​

β€”

​

$

β€”

​

​

​

​

​

​

​

Options outstanding at MarchΜύ31, 2024

Μύ

723

​

$

12.35

Μύ

0.6

years

​

$

β€”

​

Options exercisable at MarchΜύ31, 2024

Μύ

723

​

$

12.35

Μύ

0.6

years

​

$

β€”

​

​

​